Medical University of South Carolina
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Medical University of South Carolina sits in the top decile of US sponsors by registered trial count (#44 of 15,742 sponsors by registered trial count).
Medical University of South Carolina: 755 sponsored US clinical trials, 142 recruiting.
Medical University of South Carolina sponsors 755 registered US clinical trials on ClinicalTrials.gov, 142 of them currently recruiting, and 520 completed. 66 of these trials are in Phase 3-4 (later-stage) and 228 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Stroke, with 15 trials.
Top-decile sponsor footprint
Medical University of South Carolina ranks in the top decile of sponsors by registered trial count (#44 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
520 of 580 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (89.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
755 total, page 13 of 16
Prevention of Photoparoxysmal Abnormalities by Mozart K448
NCT01363154
Confidential IPV Screening Tool
NCT06284148
Ovarian Hormones and Stress Induced Drug Craving
NCT02098434
Balancing Lupus Experiences With Stress Strategies
NCT01351662
Impact of Vitamin D on Diabetic Kidney Disease in African Americans
NCT01214356
Efficacy Of Copper To Reduce Acquisition Of Microbes and Healthcare-acquired Infections
NCT01565798
Aneurysm Wall Histology Registry
NCT01444664
Allogeneic Hematopoietic Stem Cell Transplantation With Reduced Intensity Pre-transplant Conditioning for the Treatment of High-risk Hematological Malignancies (V3)
NCT01139164
Treatment of Chronic Lymphocytic Leukemia in Patients Previously Exposed to Rituximab
NCT01123356
Continuous Postoperative Pulse Oximetry in Patients Presenting for Total Hip and Total Knee Replacement
NCT01189565
The Impact of Real-time Functional Magnetic Resonance Imaging (fMRI) Feedback on Response to Nicotine Cues
NCT01411007
Spectralis HRA+OCT Imaging of the Retina With Autofluorescence in Sickle Cell Disease
NCT01123369
Treatment of Alcohol Dependence and Comorbid Bipolar Disorder
NCT01015586
Neuromodulation of Trauma Memories in PTSD & Alcohol Dependence
NCT01055171
Immediate Versus Delayed Insertion of Implanon in Postpartum Adolescents
NCT03585504
Management of Allergic Rhinitis Patients With Nasal Steroids and NeilMed® Sinus Rinse™ System With Isotonic Saline
NCT01030146
Study of Panobinostat in Combination With Sorafenib in Kidney, Soft Tissue or Lung Cancers
NCT01005797
Effects of Transcranial Magnetic Stimulation (TMS) and Stimulus Controllability on Pain Perception
NCT01030133
The Effectiveness of Transcranial Direct Current Stimulation (tDCS) in Decreasing Food Cravings
NCT01030289
Buspirone Treatment for Marijuana Dependence
NCT00875836
A Trial of N-Acetylcysteine (an Over-the-Counter Medicine) in Adolescents Who Smoke Marijuana
NCT01005810
Critical Care Excellence in Sepsis and Trauma
NCT01426711
Pediatric Metabolic Syndrome Study
NCT03570840
A Study of Intraventricular Liposomal Encapsulated Ara-C (DepoCyt) in Patients With Recurrent Glioblastoma
NCT01044966
Surgical Versus Non-surgical Staging of Lung Cancer
NCT01117714
Sirolimus Conversions in African-American Renal Transplant Recipients
NCT01005706
Sex Differences in Attentional Bias in Marijuana-dependent Individuals
NCT01179425
Research on Outpatient Adolescent Treatment for Comorbid Substance Use and Internalizing Disorders
NCT01117753
Smoking Cessation Intervention in Public Housing
NCT01035151
Alendronate in Juvenile Osteoporosis
NCT00920075
Genetic and Brain Mechanisms of Naltrexone's Treatment Efficacy for Alcoholism
NCT00920829
Transcranial Magnetic Stimulation Effects on Nicotine Craving
NCT01690130
Accuracy of the Galilei Analyzer to Calculate the Effective Corneal Power After Corneal Refractive Surgery
NCT00934804
Prevention of Post Sexual Assault Stress
NCT01430624
Impact of Varenicline on Blood-Oxygen-Level Dependent (BOLD) Functional Magnetic Resonance Imaging (fMRI) Activation on Smokers
NCT00934024
The Efficacy of Automated Intermittent Boluses for Continuous Femoral Nerve Block: a Prospective, Randomized Comparison to Continuous Infusions
NCT01226927
Gender Differences in Response to Nicotine Replacement Therapy and De-Nicotinized Cigarettes
NCT00960778
Bevacizumab and Erlotinib or Sorafenib as First-Line Therapy in Treating Patients With Advanced Liver Cancer
NCT00881751
Safety and Efficacy Study of Thymoglobulin Versus IL2 Receptor Antagonists
NCT00859131
Multifocals and Accommodating/Bilateral Implantation of Different Multifocal Intraocular Lens (IOLs)
NCT00934960
Gender and Neural Substrates of Stress and Craving
NCT00756925
Effects of Modafinil in Methamphetamine Dependence
NCT00751023
Beta-blockade Effects on Memory for Cocaine Craving
NCT00830362
Quadriceps Muscle Plasticity in Children With Cerebral Palsy
NCT00629070
Phased Treatment for Social Anxiety Disorder and Coping Behaviors in a Medical Setting
NCT00862212
Ambrisentan (Letairis) for Sarcoidosis Associated Pulmonary Hypertension
NCT00851929
Pioglitazone and Serum Asymmetric Dimethylarginine (ADMA) in Patients With Diabetes
NCT00770367
A Pilot Study to Evaluate a Revised Method of Assessing Food in a Commercial Weight Management Program Format
NCT00780468
Stenting vs. Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis
NCT00576693
Targeting HIV Risk Behaviors in Juvenile Drug Court-Involved Youth
NCT01511380
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 104 |
| Phase 2 | 124 |
| Phase 3 | 23 |
| Phase 4 | 43 |
Therapeutic Areas
What is open in the Medical University of South Carolina pipeline
142 recruiting of 755 indexed (19% open); 520 completed (69%).
Phase mix: 66 late (III/IV) vs 228 early (I/II) (early-phase heavy).
Top condition: Stroke (15 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Medical University of South Carolina: open-pipeline peers nationwide
Peers matched on 755 registered trials and 19% open enrollment, not the therapeutic-area sidebar.
Medical University of South Carolina sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 755 trials (± recruiting share)
- University of California, San Diego · 775 trials · 18% recruiting
- The University of Texas Health Science Center, Houston · 732 trials · 20% recruiting
- Dana-Farber Cancer Institute · 781 trials · 14% recruiting
- University of Miami · 721 trials · 20% recruiting
Sponsors near 19% open enrollment (± trial volume)
- Spaulding Rehabilitation Hospital · 19% recruiting · 101 trials
- Ipsen · 19% recruiting · 85 trials
- EyePoint Pharmaceuticals · 19% recruiting · 16 trials
- Hebrew SeniorLife · 19% recruiting · 32 trials
Related
What to do with this Medical University of South Carolina page
755 registered trials is a research-attention snapshot, not an endorsement of Medical University of South Carolina or any single study.
- 142 of Medical University of South Carolina's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Stroke is the condition Medical University of South Carolina studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Stroke trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Medical University of South Carolina pipeline card: 755 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.